Kedi Bioscience
Kedi Bioscience makes cat-focused, human-grade biologics to treat life-threatening diseases. It uses an experimental and computational platform to discover novel biologics tailored to feline biology. Key technologies include fully feline phage display libraries and AI-guided antibody design to make species-specific antibodies and peptide therapies. The company focuses on oncology, metabolism, and inflammation, with lead programs in oncology and early pre-clinical work in metabolism. Through partnerships with veterinary providers, it aims to deliver safe, efficacious therapies at a cost comparable to current care.
Kedi Bioscience
Kedi Bioscience makes cat-focused, human-grade biologics to treat life-threatening diseases. It uses an experimental and computational platform to discover novel biologics tailored to feline biology. Key technologies include fully feline phage display libraries and AI-guided antibody design to make species-specific antibodies and peptide therapies. The company focuses on oncology, metabolism, and inflammation, with lead programs in oncology and early pre-clinical work in metabolism. Through partnerships with veterinary providers, it aims to deliver safe, efficacious therapies at a cost comparable to current care.